Effect of platelet-activating factor(PAF)antagonist SRI63-441 on ischemia-reperfusion injury of the myocardium in rats
Qingtang Wang
Abstract
Qingtang Wang
Abstract
Objective:TO study the effects of PAF antagonist SRI63-441 on ischemia-reperfusion(I/R)injury of the myocardium.Methods:Rat models of I/R were established with coronary occlusion and reperfusion of the left anterior descending artery (LAD). The rats were randomiy divided into 3groups:control group,reperfusion group and PAF goup. LAD of the rats in control group was not occluded.The rats in PAF group and reperfusion group were given SRI63-441(lmg/kg)and BSA-phosphoric-acid buffer solution by intravenous injection one minute before the occlusion of LAD,respectively.The change of arrhythmia,myocardial infarct size(MIS),superoside dismutase(SOD)activity and malondialdehyde(MDA)level were measured.Results:The MIS,severity of arrhythmia and levels of MDA decreased,while the activities of SOD increased.Conclusion:PAF might be an important mediator involved in myocardial reperfusion injury.PAF antagonist may be useful in the treatment of myocardial I/R injury.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:TO study the effects of PAF antagonist SRI63-441 on ischemia-reperfusion(I/R)injury of the myocardium.Methods:Rat models of I/R were established with coronary occlusion and reperfusion of the left anterior descending artery (LAD). The rats were randomiy divided into 3groups:control group,reperfusion group and PAF goup. LAD of the rats in control group was not occluded.The rats in PAF group and reperfusion group were given SRI63-441(lmg/kg)and BSA-phosphoric-acid buffer solution by intravenous injection one minute before the occlusion of LAD,respectively.The change of arrhythmia,myocardial infarct size(MIS),superoside dismutase(SOD)activity and malondialdehyde(MDA)level were measured.Results:The MIS,severity of arrhythmia and levels of MDA decreased,while the activities of SOD increased.Conclusion:PAF might be an important mediator involved in myocardial reperfusion injury.PAF antagonist may be useful in the treatment of myocardial I/R injury.
Key concepts: Malondialdehyde, Antagonist, Platelet-activating factor, Reperfusion injury, Medicine, Occlusion, Ischemia, Receptor antagonist